MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

131.21 +4.12 (+3.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,122,369
Open 131.31
Bid (Size) 107.00 (100)
Ask (Size) 148.96 (100)
Prev. Close 127.09
Today's Range 130.28 - 134.23
52wk Range 109.66 - 175.77
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener... 
Via StockStory
Topics Economy
News headline image
1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory

Performance

YTD
-20.2%
-20.2%
1 Month
+11.6%
+11.6%
3 Month
-19.7%
-19.7%
6 Month
-15.1%
-15.1%
1 Year
-0.3%
-0.3%

More News

Read More
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Avoid
Via StockStory
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government Stocks
Repligen Corp (NASDAQ:RGEN) Stock Falls Despite Q4 Earnings Beat as 2026 Guidance Disappoints ↗
Via Chartmill
Topics Earnings
News headline image
1 High-Flying Stock with Solid Fundamentals and 2 We Avoid
Via StockStory
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Question
Via StockStory
News headline image
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
News headline image
2 Growth Stocks Set to Flourishand 1 We Turn Down
Via StockStory
News headline image
3 Profitable Stocks We Keep Off Our Radar
Via StockStory
Brown Capital Dumps 190,000 AppFolio Shares Worth $45.1 Million ↗
Via The Motley Fool
News headline image
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
News headline image
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
News headline image
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
Repligen (RGEN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Repligen (NASDAQ:RGEN) Exceeds Q4 CY2025 Expectations
Via StockStory
News headline image
Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 We Avoid
Via StockStory
News headline image
3 Volatile Stocks Walking a Fine Line
Via StockStory
News headline image
2 Cash-Producing Stocks to Target This Week and 1 We Ignore
Via StockStory
News headline image
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
3 High-Flying Stocks That Fall Short
Via StockStory
News headline image
Why Repligen (RGEN) Shares Are Sliding Today
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges
Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 131.21
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 04/17/26 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 7.31B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story